Kabigef 250mg Tablet

Introduction to Kabigef 250mg Tablet

Kabigef 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective in cases where the cancer has certain genetic mutations called EGFR mutations. This tablet is usually prescribed to patients who have not undergone chemotherapy before.

Composition of Kabigef 250mg Tablet

The active ingredient in Kabigef 250mg Tablet is Gefitinib. Gefitinib is a type of drug known as an EGFR tyrosine kinase inhibitor, which helps in blocking the signals that promote cancer cell growth.

Uses of Kabigef 250mg Tablet

• Treatment of locally advanced non-small cell lung cancer (NSCLC)
• Treatment of metastatic NSCLC with specific EGFR mutations

Side effects of Kabigef 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Kabigef 250mg Tablet

Before taking Kabigef 250mg Tablet, it is important to consider the following precautions:

• Do not take if you do not have EGFR mutations.
• Avoid if you are pregnant or breastfeeding.
• Not recommended for individuals with severe liver or kidney disease.
• Should not be used by those with a history of interstitial lung disease.
• Avoid if you are allergic to Gefitinib or any of its ingredients.

How to Take Kabigef 250mg Tablet

• Take one tablet orally once daily.
• Consume at the same time each day for best results.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Kabigef 250mg Tablet

Kabigef 250mg Tablet is a targeted therapy for treating certain types of lung cancer. It is crucial to follow your healthcare provider's guidance and report any side effects immediately. Always ensure that you are a suitable candidate for this medication by discussing your medical history with your doctor.